FDA authorizes first interoperable, automated insulin dosing controller

Source:
US Food and Drug Administration - FDA
Publisher:
US Food and Drug Administration
Publication date:
13 December 2019

Abstract

The FDA has authorised marketing of the Tandem Diabetes Care Control – IQ Technology. This device automatically adjusts insulin delivery by connecting to an alternate controller-enabled insulin pump and integrated continuous glucose monitor.